T1	Action 64 70;71 80	paying attention
T2	Concept 88 96	COVID-19
T3	Concept 51 58	parents
T4	Concept 97 105	epidemic
R1	in-context Arg1:T4 Arg2:T2	
R2	subject Arg1:T1 Arg2:T3	
R3	target Arg1:T1 Arg2:T4	
T5	Concept 148 153	4.32%
T6	Action 165 171	adjust
R4	in-context Arg1:T5 Arg2:T3	
R5	subject Arg1:T6 Arg2:T5	
T7	Concept 176 193	medication dosage
R6	target Arg1:T6 Arg2:T7	
T8	Concept 194 199	based
T9	Concept 209 217	previous
T10	Concept 226 235	knowledge
T11	Concept 240 250	experience
T12	Concept 218 225	medical
R7	has-property Arg1:T10 Arg2:T12	
R8	has-property Arg1:T11 Arg2:T12	
R9	has-property Arg1:T6 Arg2:T8	
R10	in-time Arg1:T10 Arg2:T9	
R11	in-time Arg1:T11 Arg2:T9	
R12	in-context Arg1:T8 Arg2:T10	
R13	in-context Arg1:T8 Arg2:T11	
R14	in-context Arg1:T6 Arg2:T1	
T13	Concept 301 316	lymphocytopenia
T14	Concept 289 297	severity
R15	in-context Arg1:T14 Arg2:T13	
T15	Concept 336 344	severity
A1	Uncertain T15
T16	Concept 348 356	COVID-19
R16	in-context Arg1:T15 Arg2:T16	
R17	entails Arg1:T14 Arg2:T15	
T17	Concept 382 392	SARS-CoV-2
T18	Action 405 411	attack
A2	Uncertain T18
T19	Action 416 423	destroy
A3	Uncertain T19
T20	Concept 428 438	lymphocyte
R18	subject Arg1:T18 Arg2:T17	
R19	subject Arg1:T19 Arg2:T17	
R20	target Arg1:T19 Arg2:T20	
R21	target Arg1:T18 Arg2:T20	
R22	entails Arg1:T18 Arg2:T14	
R23	entails Arg1:T19 Arg2:T14	
T21	Concept 496 504	COVID-19
T22	Concept 505 510	cases
R24	in-context Arg1:T22 Arg2:T21	
T23	Concept 514 519	China
T24	Concept 479 485	44,672
R25	in-context Arg1:T24 Arg2:T22	
R26	in-place Arg1:T24 Arg2:T23	
T25	Concept 526 530	2.1%
R27	in-context Arg1:T25 Arg2:T24	
T26	Concept 539 557	pediatric patients
R28	has-property Arg1:T25 Arg2:T26	
T27	Concept 559 575	â‰¤19 years of age
R29	has-property Arg1:T26 Arg2:T27	
T28	Concept 592 598	levels
T29	Concept 602 610	elevated
T30	Concept 611 614	ALT
T31	Concept 619 622	AST
R30	has-property Arg1:T30 Arg2:T29	
R31	has-property Arg1:T31 Arg2:T29	
T32	Concept 641 645	high
A4	Negated T32
A5	Uncertain T32
R32	in-context Arg1:T28 Arg2:T30	
R33	in-context Arg1:T28 Arg2:T31	
R34	has-property Arg1:T28 Arg2:T32	
T33	Concept 646 658	on admission
R35	in-time Arg1:T28 Arg2:T33	
T34	Concept 688 705	COVID-19 -related
T35	Concept 706 711	liver
T36	Concept 712 718	injury
R36	in-place Arg1:T36 Arg2:T35	
R37	has-property Arg1:T36 Arg2:T34	
R38	entails Arg1:T28 Arg2:T36	
T37	Concept 726 733	serious
A6	Negated T37
T38	Concept 741 754	initial stage
R39	has-property Arg1:T36 Arg2:T37	
R40	in-time Arg1:T36 Arg2:T38	
T40	Concept 829 839;840 855	peripheral lymphocytopenia
T41	Concept 868 875	crucial
T43	Concept 880 886	common
T39	Concept 887 894	feature
R41	has-property Arg1:T39 Arg2:T43	
R42	has-property Arg1:T39 Arg2:T41	
T42	Concept 899 907	COVID-19
T44	Action 908 917	infection
R43	subject Arg1:T44 Arg2:T42	
R44	in-context Arg1:T39 Arg2:T44	
R45	is-a Arg1:T40 Arg2:T39	
